Actualités Crescita Therapeutics Inc - CTX | Actions Toronto Stock Exchange

Crescita Reports Third Quarter 2024 Results

Crescita Therapeutics Inc. (TSX: CTX and OTC US: CRRTF) (“Crescita” or the “Company”), a growth-oriented, innovation-driven Canadian commercial...

Crescita Therapeutics Announces Approval of Normal Course Issuer Bid

Crescita Therapeutics Inc. (TSX: CTX and OTC US: CRRTF) (“Crescita” or the “Company”), a growth-oriented, innovation-driven Canadian commercial...

Crescita to Present & Participate in 1x1 Meetings at the Planet MicroCap Showcase: VANCOUVER 2024 in Association with Small Cap Discoveries on Thursday, September 26, 2024

Crescita Therapeutics Inc. (TSX: CTX and OTC US: CRRTF) (“Crescita” or the “Company”), a growth-oriented, innovation-driven Canadian commercial...

Crescita Reports Second Quarter 2024 Results

Secures Manufacturing Contract of US$10 Million over 4 Years Completes Strategic Asset Acquisition Crescita Therapeutics Inc. (TSX: CTX and...

Crescita Secures Contract Manufacturing Revenue of $US10 Million Over 4 Years

Crescita Therapeutics Inc. (TSX: CTX and OTC US: CRRTF) (“Crescita” or the “Company”), a growth-oriented, innovation-driven Canadian commercial...

Leading Canadian Healthcare Services Provider Selects Crescita as Exclusive Manufacturing Partner under 5-Year Agreement

Crescita Therapeutics Inc. (TSX: CTX and OTC US: CRRTF) (“Crescita” or the “Company”), a growth-oriented, innovation-driven Canadian commercial...

Crescita Expands Medical Aesthetic Portfolio with MicronJetTM600 The World’s Smallest Intradermal Delivery Device

Crescita Therapeutics Inc. (TSX: CTX and OTC US: CRRTF) (“Crescita” or the “Company”), a growth-oriented, innovation-driven Canadian commercial...

Crescita Completes Acquisition of Strategic Assets of Occy Laboratory

Crescita Therapeutics Inc. (TSX: CTX and OTC US: CRRTF) (“Crescita” or the “Company”), a growth-oriented, innovation-driven Canadian commercial...

Crescita to Acquire Strategic Assets of Occy Laboratory

Crescita Therapeutics Inc. (TSX: CTX and OTC US: CRRTF) (“Crescita” or the “Company”), a growth-oriented, innovation-driven Canadian commercial...

Crescita Therapeutics Announces the Results of its Annual General and Special Meeting of Shareholders

Crescita Therapeutics Inc. (TSX: CTX and OTC US: CRRTF) (“Crescita” or the “Company”), a growth-oriented, innovation-driven Canadian commercial...

Crescita Reports First Quarter 2024 Results

Crescita Therapeutics Inc. (TSX: CTX and OTC US: CRRTF) (“Crescita” or the “Company”), a growth-oriented, innovation-driven Canadian commercial...

Crescita Reports Q4 and Fiscal 2023 Results

Crescita Therapeutics Inc. (TSX: CTX and OTC US: CRRTF) (“Crescita” or the “Company”), a growth-oriented, innovation-driven Canadian commercial...

Crescita Reports Third Quarter 2023 Results

Crescita Therapeutics Inc. (TSX: CTX and OTC US: CRRTF) (“Crescita” or the “Company”), a growth-oriented, innovation-driven Canadian commercial...

Crescita Therapeutics Announces Approval of Normal Course Issuer Bid

Crescita Therapeutics Inc. (TSX: CTX) (OTC US: CRRTF) (“Crescita” or the “Company”) announced today that the Toronto Stock Exchange (the “TSX”...

Crescita Reports Second Quarter 2023 Results

Crescita Therapeutics Inc. (TSX: CTX and OTC US: CRRTF) (“Crescita” or the “Company”), a growth-oriented, innovation-driven Canadian commercial...

	Prix en temps réel	Carnet d'ordres
BATS Europe
Chi-X Europe
Euronext

	Prix en temps réel	Carnet d'ordres
BATS Europe
Chi-X Europe
Euronext

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

Crescita Therapeutics Inc (CTX)

Donnez du pouvoir à votre portefeuille : discussions en temps réel et idées de trading exploitables.

CTX Actualités

Crescita Reports Third Quarter 2024 Results

Crescita Therapeutics Announces Approval of Normal Course Issuer Bid

Crescita to Present & Participate in 1x1 Meetings at the Planet MicroCap Showcase: VANCOUVER 2024 in Association with Small Cap Discoveries on Thursday, September 26, 2024

Crescita Reports Second Quarter 2024 Results

Crescita Secures Contract Manufacturing Revenue of $US10 Million Over 4 Years

Leading Canadian Healthcare Services Provider Selects Crescita as Exclusive Manufacturing Partner under 5-Year Agreement

Crescita Expands Medical Aesthetic Portfolio with MicronJetTM600 The World’s Smallest Intradermal Delivery Device

Crescita Completes Acquisition of Strategic Assets of Occy Laboratory

Crescita to Acquire Strategic Assets of Occy Laboratory

Crescita Therapeutics Announces the Results of its Annual General and Special Meeting of Shareholders

Crescita Reports First Quarter 2024 Results

Crescita Reports Q4 and Fiscal 2023 Results

Crescita Reports Third Quarter 2023 Results

Crescita Therapeutics Announces Approval of Normal Course Issuer Bid

Crescita Reports Second Quarter 2023 Results

Forums

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application

Vendredi fou

Jusqu'à 65% de réduction sur Intégral

Cours Euronext Niveau 1 et carnet d'ordres

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

Crescita Therapeutics Inc (CTX) Actualités

Crescita Therapeutics Inc (CTX)

Donnez du pouvoir à votre portefeuille : discussions en temps réel et idées de trading exploitables.

CTX Actualités

Crescita Reports Third Quarter 2024 Results

Crescita Therapeutics Announces Approval of Normal Course Issuer Bid

Crescita to Present & Participate in 1x1 Meetings at the Planet MicroCap Showcase: VANCOUVER 2024 in Association with Small Cap Discoveries on Thursday, September 26, 2024

Crescita Reports Second Quarter 2024 Results

Crescita Secures Contract Manufacturing Revenue of $US10 Million Over 4 Years

Leading Canadian Healthcare Services Provider Selects Crescita as Exclusive Manufacturing Partner under 5-Year Agreement

Crescita Expands Medical Aesthetic Portfolio with MicronJetTM600 The World’s Smallest Intradermal Delivery Device

Crescita Completes Acquisition of Strategic Assets of Occy Laboratory

Crescita to Acquire Strategic Assets of Occy Laboratory

Crescita Therapeutics Announces the Results of its Annual General and Special Meeting of Shareholders

Crescita Reports First Quarter 2024 Results

Crescita Reports Q4 and Fiscal 2023 Results

Crescita Reports Third Quarter 2023 Results

Crescita Therapeutics Announces Approval of Normal Course Issuer Bid

Crescita Reports Second Quarter 2023 Results

Forums

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application

Vendredi fou

Jusqu'à 65% de réduction sur Intégral

Cours Euronext Niveau 1 et carnet d'ordres